Layer 2 Entorhinal Cortex Neurons In Alzheimer Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
The entorhinal cortex (EC) serves as the major gateway between the neocortex and hippocampus. Layer 2 (L2) contains projection neurons (stellate cells) that are among the first neurons to show pathology in AD.
- Morphology: Spiny, stellate-shaped
- Location: Layer II of EC
- Projections: To dentate gyrus (perforant path)
- Markers: Reelin, WFS1
- Function: Spatial representation
- Properties: Hexagonal firing fields
- Impairment: Early in AD
- Stage I: EC L2 neurons affected first
- Transentorhinal cortex: Next stage
- Pathology spread: Then to hippocampus
- High metabolic demand: Continuous activity
- Tau susceptibility: Early tau accumulation
- Connectivity: Major hub neuron
- Location: Gateway position
- Neurofibrillary tangles: In cell bodies
- Dendritic tau: In processes
- Pre-tangle state: Early changes
- Limited direct deposition: Neuritic plaques nearby
- Synaptic dysfunction: Early loss
- Network effects: Hyperconnectivity changes
- Neuron loss: Up to 70% in severe AD
- Atrophy: Layer II volume reduction
- Dendritic retraction: Loss of spines
- Episodic memory: Early deficits
- Spatial memory: Navigation problems
- Contextual memory: Association loss
- Perforant path: Input to hippocampus disrupted
- EC-hippocampal loop: Broken
- Computational failure: Pattern separation
- CSF biomarkers: Tau, β-amyloid
- Imaging: EC atrophy on MRI
- FDG-PET: Hypometabolism
- Anti-tau therapies: Immunotherapies
- Neuroprotective: Save L2 neurons
- Network repair: Restore connectivity
- Post-mortem studies: Human tissue analysis
- Neuroimaging: In vivo assessment
- iPSC models: Patient-derived neurons
- Animal models: Transgenic AD models
The study of Layer 2 Entorhinal Cortex Neurons In Alzheimer Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Gómez-Isla T, et al. (1996). Neuronal loss and NFT in entorhinal cortex. Ann Neurol.
- Hyman BT, et al. (1984). Alzheimer's disease: cell-specific pathology. J Neuropathol Exp Neurol.
- Van Hoesen GW, et al. (1991). Entorhinal cortex pathology in AD. Acta Neuropathol.